A Study to Evaluate the Glucagon and Incretin Responses and Identify the Role of Extrapancreatic Glucagon in Patients with Fibrocalcific Pancreatic Diabetes

被引：0
|
作者：
Shankar, Anand
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-224-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
224-LB
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes
    Dankner, Rachel
    Murad, Havi
    Agay, Nirit
    Olmer, Liraz
    Freedman, Laurence S.
    JAMA NETWORK OPEN, 2024, 7 (01) : E2350408
  • [32] In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis
    Petrenko, Volodymyr
    Gandasi, Nikhil R.
    Sage, Daniel
    Tengholm, Anders
    Barg, Sebastian
    Dibner, Charna
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (05) : 2484 - 2495
  • [33] The Impact of Pancreatic Enzyme Supplementation on Postprandial Responses of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency
    Knop, Filip K.
    Vilsboll, Tina
    Lund, Asger
    Krarup, Thure
    Holst, Jens J.
    Hornum, Mads
    JOURNAL OF THE PANCREAS, 2010, 11 (05): : 489 - 491
  • [34] Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study
    Dybjer, E.
    Engstrom, G.
    Helmer, C.
    Nagga, K.
    Rorsman, P.
    Nilsson, P. M.
    DIABETIC MEDICINE, 2020, 37 (07) : 1157 - 1166
  • [35] Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
    Yang, Hae Kyung
    Kang, Borami
    Lee, Seung-Hwan
    Kim, Hun-Sung
    Yoon, Kun-Ho
    Cha, Bong-Yun
    Cho, Jae-Hyoung
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 335 - 341
  • [36] SIGNIFICANCE OF STUDY OF GLUCAGON LEVELS IN REACTIVE HYPOGLYCEMIAS OF PATIENTS WITH CHEMICAL DIABETES BEFORE AND AFTER PECTIN TREATMENT
    BRINGER, J
    MONNIER, L
    PHAM, TC
    AGUIRRE, L
    ORSETTI, A
    MIROUZE, J
    DIABETES & METABOLISM, 1978, 4 (03): : 218 - 218
  • [37] Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
    Yeow, Toh Peng
    Pacini, Giovanni
    Tura, Andrea
    Hor, Chee Peng
    Lim, Shueh Lin
    Tan, Florence Hui Sieng
    Tong, Chin Voon
    Hong, Janet Yeow Hua
    Zain, Fuziah Md
    Holst, Jens Juul
    Mohamud, Wan Nazaimoon Wan
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [38] Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
    Hiroyoshi, M
    Tateishi, K
    Yasunami, Y
    Maeshiro, K
    Ono, J
    Matsuoka, Y
    Ikeda, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (04): : 976 - 981
  • [39] Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients
    Ishibashi, Chisaki
    Kozawa, Junji
    Hosakawa, Yoshiya
    Yoneda, Sho
    Kimura, Takekazu
    Fujita, Yukari
    Fukui, Kenji
    Iwahashi, Hiromi
    Shimomura, Iichiro
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (01) : 80 - 87
  • [40] Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus
    Shiota, D
    Kasamatsu, T
    Dib, SA
    Chacra, AR
    Moisés, RS
    PANCREAS, 2002, 24 (04) : 386 - 390
12345